Nodular lymphomas: current concepts (Q39736050)

14 September 2017

1 reference

title

Nodular lymphomas: current concepts (English)

1 reference

14 September 2017

3

Longo DL

1 reference

14 September 2017

Matis LA

1

1 reference

14 September 2017

Young RC

series ordinal

2

1 reference

14 September 2017

publication date

1 January 1986

1 reference

Critical Reviews in Oncology Hematology

14 September 2017

published in

1 reference

14 September 2017

volume

5

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

171-197

1 reference

Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Non-Hodgkin's lymphomas: a clinicopathologic study of 293 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Malignant lymphoma, intermediate lymphocytic type: a clinicopathologic study of 42 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Nodular Lymphoma — Evidence for Origin from Follicular B Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Nodular histiocytic lymphoma: factors influencing prognosis and implications for aggressive chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Sequential nonsurgical and surgical staging of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Circulating monoclonal B lymphocytes in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and II

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

CVP—Remission—maintenance in stage I or II non-Hodgkin's lymphomasPreliminary results of a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Laparotomy staged I and II non-Hodgkin's lymphomas: preliminary results of radiotherapy and adjunctive chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Advanced Lymphosarcoma: Intensive Cyclical Combination Chemotherapy with Cyclophosphamide, Vincristine, and Prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Prolonged Initial Remission in Patients with Nodular Mixed Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

A comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Malignant lymphoma. II Prognostic factors and response to treatment of 473 patients at the National Cancer Institute

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Non-Hodgkin's lymphoma: Patterns of relapse from complete remission after combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Recurrence Rates Following Radiation Therapy of Nodular and Diffuse Malignant Lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

No Initial Therapy for Stage III and IV Non-Hodgkin's Lymphomas of Favorable Histologic Types

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

The natural history of initially untreated low-grade non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Histologic conversion in the non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Malignant lymphomas of follicular center cell origin in humans. V. Incidence, clinical features, and prognostic implications of transformation of small cleaved cell nodular lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Natural history of malignant lymphomas with divergent histologies at staging evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

The coexistence of nodular and diffuse patterns in nodular non-Hodgkin's lymphomas.Significance and clinicopathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Non-Hodgkin's lymphomas of stage III extent. Is total lymphoid irradiation appropriate treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

The role of radiation therapy in the management of stage III follicular lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Stage III nodular lymphoreticular tumors (non-Hodgkin's lymphoma): Results of central lymphatic irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Stage III nodular lymphomas. Preliminary results of a combined chemotherapy/radiotherapy program

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

High-dose pulse chlorambucil: effective therapy for rapid remission induction in nodular lymphocytic poorly differentiated lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Comparison of M-2 protocol with COP in patients with nodular lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Expression of cell surface markers after human B lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Malignant lymphoma, well differentiated lymphocytic.Its relationship with chronic lymphocytic leukemia and macroglobulinemia of Waldenström

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Human neoplastic B cells: monoclonal models of B-cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Induction of differentiation in a case of common acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

In vitro enhancement of immunoglobulin gene expression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Spontaneous regression of non-Hodgkin's lymphoma: a report of nine cases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

A cloned human T cell line cytotoxic for autologous and allogeneic B lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Regulation of B cell lymphomagenesis by a malignant Qal+ inducer T cell clone.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Induction of T and B cell immunity by anti-idiotypic antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Biclonal B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotype

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Non-Hodgkin's lymphomas in leukemic phase: clinicopathologic correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Immunopathology of follicular lymphomas. A model of B-lymphocyte homing

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Human immunoglobulin kappa light-chain genes are deleted or rearranged in lambda-producing B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Frequent biclonality and Ig gene alterations among B cell lymphomas that show multiple histologic forms

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980024-5

7 January 2021

10.1016/S1040-8428(86)80024-5

Identifiers

DOI

1 reference

release_xspfdtfuwfbotmygq7gkflf2gi

14 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xspfdtfuwfbotmygq7gkflf2gi

24 November 2022

mapped directly with Wikidata item

1 reference